|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0020538,
umls-concept:C0030705,
umls-concept:C0126174,
umls-concept:C0149721,
umls-concept:C0301630,
umls-concept:C0441471,
umls-concept:C1948041,
umls-concept:C2349179,
umls-concept:C2603343,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-12-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
We assessed readily available patient characteristics, including albuminuria (not included in traditional cardiovascular risk scores), as predictors of cardiovascular events in hypertension with left ventricular hypertrophy (LVH) and developed risk algorithms/scores for outcomes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1651-1999
|
|
pubmed:author |
pubmed-author:DahlöfBjörnB,
pubmed-author:DevereuxRichard BRB,
pubmed-author:EdelmanJonathan MJM,
pubmed-author:FyhrquistFrejF,
pubmed-author:HilleDarcy ADA,
pubmed-author:IbsenHansH,
pubmed-author:JuliusStevoS,
pubmed-author:KjeldsenSverre ESE,
pubmed-author:Lederballe-PedersenOleO,
pubmed-author:LindholmLars HLH,
pubmed-author:LylePaulette APA,
pubmed-author:NieminenMarkku SMS,
pubmed-author:OparilSuzanneS,
pubmed-author:OpdamHH,
pubmed-author:SnapinnSteven MSM,
pubmed-author:WedelHansH,
pubmed-author:de FaireUlfU
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
348-61
|
|
pubmed:meshHeading |
pubmed-meshheading:20001655-Aged,
pubmed-meshheading:20001655-Aged, 80 and over,
pubmed-meshheading:20001655-Antihypertensive Agents,
pubmed-meshheading:20001655-Atenolol,
pubmed-meshheading:20001655-Blood Pressure,
pubmed-meshheading:20001655-Double-Blind Method,
pubmed-meshheading:20001655-Female,
pubmed-meshheading:20001655-Follow-Up Studies,
pubmed-meshheading:20001655-Humans,
pubmed-meshheading:20001655-Hypertension,
pubmed-meshheading:20001655-Hypertrophy, Left Ventricular,
pubmed-meshheading:20001655-Losartan,
pubmed-meshheading:20001655-Male,
pubmed-meshheading:20001655-Middle Aged
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
|
|
pubmed:affiliation |
University of Oslo, Ullevaal Hospital, N-0407 Oslo, Norway. s.e.kjeldsen@medisin.uio.no
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
